Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis
Authors:
- Camille LochtCLCamille Locht
- Jean-Michel HougardyJHJean-Michel Hougardy
- Carine RouanetCRCarine Rouanet
- Sammy PlaceSPSammy Place
- Françoise MascartFMFrançoise Mascart
- 1 May 2006
- journal article
- review article
- Published by Elsevier in Tuberculosis
- Vol. 86 (3-4) , 303-309
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The tuberculosis vaccine challengeTuberculosis, 2005
- Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infectionThe Lancet Infectious Diseases, 2003
- Mycobacterium tuberculosis: here today, and here tomorrowNature Reviews Molecular Cell Biology, 2001
- Effective Preexposure Tuberculosis Vaccines Fail To Protect When They Are Given in an Immunotherapeutic ModeInfection and Immunity, 2000
- Persistent T cell and B cell activities in the duodenal mucosa of AIDS patientsAIDS, 1998
- Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in MalawiThe Lancet, 1996
- Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literatureJAMA, 1994
- Tuberculosis in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- GROWTH CHARACTERISTICS OF TUBERCLE BACILLI AND CERTAIN OTHER MYCOBACTERIA IN HELA CELLSJournal of Experimental Medicine, 1957
- Types of tubercle bacilli in human tuberculosisThe Journal of Pathology and Bacteriology, 1929